Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Ehinger

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cell Chemical Biology|February 16, 2024
Cellular reprogramming by protein degradation: The next frontier in cancer immunotherapyErik Ehinger, Anjana Rao
The Journal of Headache and Pain|April 18, 2026
Trigeminal neuralgia is associated with increased risk of cerebrovascular disease, myocardial infarction and suicide - a nationwide Swedish studyErik Ehinger, Erik Kronvall, Erik Uvelius
Cancers|June 12, 2026
Has Glioblastoma Five- and Ten-Year Survival Been Affected by New Treatment Algorithms in Population-Based Data? A Retrospective Swedish Survey Between 1958 and 2015Peter Milos, Erik Ehinger, Edward Visse, et al.
Current Opinion in Lipidology|July 19, 2018
Atherosclerosis in the single-cell eraHolger Winkels, Erik Ehinger, Yanal Ghosheh, et al.
BMC Neurology|February 21, 2023
Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastomaErik Ehinger, Jan Kopecky, Anna Darabi, et al.
Circulation Research|March 18, 2017
Endothelial Protective Monocyte Patrolling in Large Arteries Intensified by Western Diet and AtherosclerosisAmado Quintar, Sara McArdle, Dennis Wolf, et al.
International Journal of Cardiology|November 23, 2015
Prognostic impact of macrophage migration inhibitory factor in patients with non-ischemic heart failure undergoing endomyocardial biopsyKarin A L Mueller, Johannes Schwille, Saskia Vollmer, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Reversible control of T cell exhaustion by NR4A transcription factors revealed through targeted protein degradationErik Ehinger, Kristy C Perez, Emi Sanchez, et al.
Nature Communications|July 25, 2017
Natural variation of macrophage activation as disease-relevant phenotype predictive of inflammation and cancer survivalKonrad Buscher, Erik Ehinger, Pritha Gupta, et al.
Trials|March 14, 2025
Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trialErik Ehinger, Anna Darabi, Edward Visse, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cell Chemical Biology|February 16, 2024
Cellular reprogramming by protein degradation: The next frontier in cancer immunotherapyErik Ehinger, Anjana Rao
The Journal of Headache and Pain|April 18, 2026
Trigeminal neuralgia is associated with increased risk of cerebrovascular disease, myocardial infarction and suicide - a nationwide Swedish studyErik Ehinger, Erik Kronvall, Erik Uvelius
Cancers|June 12, 2026
Has Glioblastoma Five- and Ten-Year Survival Been Affected by New Treatment Algorithms in Population-Based Data? A Retrospective Swedish Survey Between 1958 and 2015Peter Milos, Erik Ehinger, Edward Visse, et al.
Current Opinion in Lipidology|July 19, 2018
Atherosclerosis in the single-cell eraHolger Winkels, Erik Ehinger, Yanal Ghosheh, et al.
BMC Neurology|February 21, 2023
Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastomaErik Ehinger, Jan Kopecky, Anna Darabi, et al.
Circulation Research|March 18, 2017
Endothelial Protective Monocyte Patrolling in Large Arteries Intensified by Western Diet and AtherosclerosisAmado Quintar, Sara McArdle, Dennis Wolf, et al.
International Journal of Cardiology|November 23, 2015
Prognostic impact of macrophage migration inhibitory factor in patients with non-ischemic heart failure undergoing endomyocardial biopsyKarin A L Mueller, Johannes Schwille, Saskia Vollmer, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Reversible control of T cell exhaustion by NR4A transcription factors revealed through targeted protein degradationErik Ehinger, Kristy C Perez, Emi Sanchez, et al.
Nature Communications|July 25, 2017
Natural variation of macrophage activation as disease-relevant phenotype predictive of inflammation and cancer survivalKonrad Buscher, Erik Ehinger, Pritha Gupta, et al.
Trials|March 14, 2025
Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trialErik Ehinger, Anna Darabi, Edward Visse, et al.
Pageof 3